AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Asimilar Group Plc

Share Issue/Capital Change Mar 31, 2021

6087_rns_2021-03-31_fa01a39e-dcfd-4232-a630-c967797adcb7.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2066U

Asimilar Group PLC

31 March 2021

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

31 March 2021

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

Extension of Warrant Exercise Deadline

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), announces that it has extended the expiry date in relation to the 11,562,500 warrants issued by the Company with an exercise price of 30p per share in conjunction with a placing announced on 18 December 2019 ("Warrants").  As at the time of this announcement, 3,750,000 Warrants have already been exercised. 

The Company has agreed to extend the final exercise date of the Warrants from 5pm on 31 March 2021 to 5pm on 9 April 2021.  The extension has been agreed by the relevant warrant holders and the Company pursuant to the terms of the warrant instrument.

-ends-

For further information please contact:

Asimilar Group plc
John Taylor, Non-Executive Chairman via Buchanan
Cairn Financial Advisers LLP
Sandy Jamieson / Liam Murray Tel: +44 20 7213 0880
Peterhouse Capital Limited
Duncan Vasey / Lucy Williams Tel: + 44 20 7220 9797
Buchanan Communications Limited
Richard Oldworth / Chris Lane Tel: +44 (0) 20 7466 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDKDBKOBKDBNN

Talk to a Data Expert

Have a question? We'll get back to you promptly.